River Global Investors LLP Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

River Global Investors LLP lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 26.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,735 shares of the healthcare conglomerate’s stock after selling 635 shares during the quarter. River Global Investors LLP’s holdings in UnitedHealth Group were worth $914,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Richelieu Gestion SA purchased a new stake in UnitedHealth Group during the fourth quarter valued at $26,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. NewSquare Capital LLC raised its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA raised its stake in UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares in the last quarter. Finally, Annapolis Financial Services LLC raised its stake in UnitedHealth Group by 38.6% during the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after purchasing an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of several recent analyst reports. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Piper Sandler increased their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, TD Cowen cut their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE:UNH traded down $0.52 during trading on Friday, reaching $492.45. The stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a market capitalization of $453.09 billion, a P/E ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm’s 50-day simple moving average is $482.32 and its 200 day simple moving average is $512.42.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period last year, the business earned $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.